Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Current Opinion in Drug Discovery & Development
|
July 31, 2007
Recent progress in the discovery of niacin receptor agonists
Graeme Semple, P Douglas Boatman, Jeremy G Richman
Journal of Medicinal Chemistry
|
November 6, 2008
Nicotinic acid receptor agonists
P Douglas Boatman, Jeremy G Richman, Graeme Semple
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2003
High-throughput synthesis and optimization of thrombin inhibitors via urazole alpha-addition and Michael addition
P Douglas Boatman, Jan Urban, Minh Nguyen, et al.
Current Opinion in Pharmacology
|
October 16, 2003
Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors
Robert M Jones, P Douglas Boatman, Graeme Semple, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 18, 2011
Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection
Tong Zhang, Zhuangjie Li, Huong Dang, et al.
Journal of Medicinal Chemistry
|
March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b
Jae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 11, 2015
Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in rat
Thuy-Anh Tran, Young-Jun Shin, Bryan Kramer, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2010
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109a
Tawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Current Opinion in Drug Discovery & Development
|
July 31, 2007
Recent progress in the discovery of niacin receptor agonists
Graeme Semple, P Douglas Boatman, Jeremy G Richman
Journal of Medicinal Chemistry
|
November 6, 2008
Nicotinic acid receptor agonists
P Douglas Boatman, Jeremy G Richman, Graeme Semple
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2003
High-throughput synthesis and optimization of thrombin inhibitors via urazole alpha-addition and Michael addition
P Douglas Boatman, Jan Urban, Minh Nguyen, et al.
Current Opinion in Pharmacology
|
October 16, 2003
Clinically validated peptides as templates for de novo peptidomimetic drug design at G-protein-coupled receptors
Robert M Jones, P Douglas Boatman, Graeme Semple, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
October 18, 2011
Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection
Tong Zhang, Zhuangjie Li, Huong Dang, et al.
Journal of Medicinal Chemistry
|
March 16, 2007
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b
Jae-Kyu Jung, Benjamin R Johnson, Tracy Duong, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 11, 2015
Discovery of a new series of potent prostacyclin receptor agonists with in vivo activity in rat
Thuy-Anh Tran, Young-Jun Shin, Bryan Kramer, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2010
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple, Philip J Skinner, Tawfik Gharbaoui, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 26, 2007
Agonist lead identification for the high affinity niacin receptor GPR109a
Tawfik Gharbaoui, Philip J Skinner, Young-Jun Shin, et al.
Page
of 2